Cargando…
A Live Attenuated COVID-19 Candidate Vaccine for Children: Protection against SARS-CoV-2 Challenge in Hamsters
Children are at risk of infection from severe acute respiratory syndrome coronavirus-2 virus (SARS-CoV-2) resulting in coronavirus disease (COVID-19) and its more severe forms. New-born infants are expected to receive short-term protection from passively transferred maternal antibodies from their mo...
Autores principales: | Mehla, Rajeev, Kokate, Prasad, Bhosale, Sarika R., Vaidya, Vivek, Narayanan, Shridhar, Shandil, Radha. K., Singh, Mayas, Rudramurthy, Gudepalya R., Naveenkumar, Chakenahalli N., Bharathkumar, Kumaraswamy, Coleman, Rob, Mueller, Steffen, Dhere, Rajeev M., Yeolekar, Leena R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965573/ https://www.ncbi.nlm.nih.gov/pubmed/36851133 http://dx.doi.org/10.3390/vaccines11020255 |
Ejemplares similares
-
Genomic Mutations in SARS-CoV-2 Genome following Infection in Syrian Golden Hamster and Associated Lung Pathologies
por: Rudramurthy, Gudepalya Renukaiah, et al.
Publicado: (2023) -
1938. CoviLiv™, a Novel Intranasal Live-Attenuated COVID-19 Vaccine Candidate, Induces Robust Humoral and Cellular Immunity in First-In-Human Clinical Trial CDX-CoV-001
por: Kaufmann, Johanna K, et al.
Publicado: (2023) -
Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases
por: Shandil, Radha Krishan, et al.
Publicado: (2022) -
Isolation of a High Affinity Neutralizing Monoclonal Antibody against 2009 Pandemic H1N1 Virus That Binds at the ‘Sa’ Antigenic Site
por: Shembekar, Nachiket, et al.
Publicado: (2013) -
Novel Baicalein-Derived Inhibitors of Plasmodium falciparum
por: Gudla, Chandra Sekhar, et al.
Publicado: (2023)